http://www.signaturecomms.com/news_archive/ Signature Communications News en neil@modeten.com Copyright 2011 2011-03-27T14:44:12+00:00 http://www.signaturecomms.com/news/acne_academy_retains_signature_communications/ http://www.signaturecomms.com/news/acne_academy_retains_signature_communications/#When:14:44:12Z Signature Communications has been appointed by the Acne Academy, a collaborative faculty formed by a multi-disciplinary group of healthcare professionals specialising in dermatology and more specifically, to support, develop and promote the organisation as it grows following its inception in 2009. Signature Communications Healthcare News 2011-03-27T14:44:12+00:00 http://www.signaturecomms.com/news/signature_secures_astellas_brief/ http://www.signaturecomms.com/news/signature_secures_astellas_brief/#When:14:33:23Z Japanese pharmaceutical giants Astellas have appointed dermatology experts Signature Communications to spearhead its medical education account for their atopic dermatitis treatment Protopic. Signature Communications Healthcare News 2011-03-27T14:33:23+00:00 http://www.signaturecomms.com/news/signature_communications_lands_brief_to_handle_botox_rival/ http://www.signaturecomms.com/news/signature_communications_lands_brief_to_handle_botox_rival/#When:14:33:43Z Dermatology firm Galderma has turned to Signature Communications to promote a new cosmetic product to take on market leader Botox. Signature Communications Healthcare News 2010-02-25T14:33:43+00:00 http://www.signaturecomms.com/news/basilea_brings_in_signature_communications/ http://www.signaturecomms.com/news/basilea_brings_in_signature_communications/#When:14:53:25Z Signature Communications has been brought in to support a medical education campaign for Toctino® (alitretinoin) following its approval for Repeat-use Procedure in 13 additional European Union (EU) Member States. Toctino® is a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids. Signature Communications Healthcare News 2010-02-08T14:53:25+00:00 http://www.signaturecomms.com/news/sun_smart_skin_aware_communique/ http://www.signaturecomms.com/news/sun_smart_skin_aware_communique/#When:15:23:32Z Thirty to forty years ago, sun awareness campaigns to convey skin damage did not exist. As a result, a large percentage of the UK population aged 50+ now have signs of sun damage and are widely susceptible to non-melanoma skin cancers such as actinic keratosis, basal cell carcinoma and squamous cell carcinoma. Signature Communications Healthcare News 2009-11-27T15:23:32+00:00 http://www.signaturecomms.com/news/signature_secures_scar_prevention_brief/ http://www.signaturecomms.com/news/signature_secures_scar_prevention_brief/#When:15:16:18Z Signature Healthcare Communications has been bought onboard by Cranage Healthcare to undertake the UK launch and ongoing promotion of its clinically proven scar prevention treatment, Kelo-cote®. Signature Communications Healthcare News 2009-06-03T15:16:18+00:00 http://www.signaturecomms.com/news/signature_healthcare_communications_handed_solaraze_brief/ http://www.signaturecomms.com/news/signature_healthcare_communications_handed_solaraze_brief/#When:12:04:19Z Almirall UK has appointed Signature Healthcare Communications as its UK medical education and PR agency. The agency has been appointed following a competitive pitch and will work initially on the Solaraze brand, as well as the wider dermatology portfolio later this year. Signature Communications Healthcare News 2009-04-08T12:04:19+00:00 http://www.signaturecomms.com/news/signature_healthcare_communications_secures_galderma_brief_/ http://www.signaturecomms.com/news/signature_healthcare_communications_secures_galderma_brief_/#When:17:36:37Z Dermatology experts Galderma have appointed Signature Communications to spearhead its national PR and medical education account. Signature Communications Healthcare News 2009-03-19T17:36:37+00:00 http://www.signaturecomms.com/news/a_new_face_at_signature/ http://www.signaturecomms.com/news/a_new_face_at_signature/#When:21:38:26Z Following a number of new client wins, we are thrilled to announce that from Monday 6th April we will be welcoming Carol Singleton to the team. With over six years experience working in pharmaceutical PR and events, Carol brings a wealth of experience and exceptional organisational talents to the team. Signature Communications Healthcare News 2009-03-18T21:38:26+00:00 http://www.signaturecomms.com/news/conferences_are_us/ http://www.signaturecomms.com/news/conferences_are_us/#When:21:29:21Z After three months of planning, we are now just a week away from SKCIN’s launch at the inaugural “Skin Cancer UK, A United National Strategy” conference. Signature Communications Healthcare News 2009-03-18T21:29:21+00:00